Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron therapy in anemic children with congenital acyanotic heart disease
PACTR202501496307274Not yet recruiting
- Sponsor
- Cairo University Children's Hospital
- Start
- Jan 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of ferric pyrophosphate liposomal and Iron in iron deficiency anemia (IDA) (2 arms), sponsored by Cairo University Children's Hospital. Primary endpoint: Efficacy of liposomal iron. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
ferric pyrophosphate liposomalIron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on PACTR202501496307274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202501496307274.